Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2 | -2,620 | -4,251 | -832 | -801 |
| Depreciation Amortization | N/A | 601 | 651 | 183 | 85 |
| Accounts receivable | N/A | 8 | -10 | 5 | 29 |
| Accounts payable and accrued liabilities | 1 | -139 | 177 | 334 | 25 |
| Other Working Capital | 2 | 14 | 758 | 491 | 48 |
| Other Operating Activity | -1 | 1,850 | 2,275 | -313 | -19 |
| Operating Cash Flow | $0 | $-286 | $-400 | $-131 | $-634 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3 | -1 | 0 | -13 |
| Purchase Sale Intangibles | N/A | -6 | -78 | -118 | -93 |
| Other Investing Activity | 0 | -6 | -78 | -118 | -93 |
| Investing Cash Flow | $N/A | $-9 | $-79 | $-118 | $-106 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 405 | 400 | 383 | 394 |
| Other Financing Activity | 0 | -113 | -60 | -174 | 46 |
| Financing Cash Flow | $N/A | $293 | $339 | $209 | $440 |
| Beginning Cash Position | N/A | 10 | 150 | 217 | 342 |
| End Cash Position | N/A | 8 | 10 | 177 | 42 |
| Net Cash Flow | $0 | $-2 | $-140 | $-41 | $-299 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | -286 | -400 | -131 | -634 |
| Capital Expenditure | N/A | -3 | -1 | 0 | -13 |
| Free Cash Flow | 0 | -289 | -401 | -131 | -646 |